Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

Blood Cancer Journal
Wilson I GonsalvesS Kumar

Abstract

Renal impairment (RI) is seen in over a quarter of patients with newly diagnosed multiple myeloma (NDMM). It is not clear if reversal of RI improves the outcome to that expected for NDMM patients without RI. We evaluated 1135 consecutive patients with NDMM seen at the Mayo Clinic between January 2003 and December 2012. RI was defined as having a creatinine clearance (CrCl) <40ml/min. The median overall survival (OS) for patients with RI at diagnosis receiving and not receiving novel agent induction therapy was not reached vs 46 months (P<0.001). The median OS for patients with CrCl ⩾40 ml/min at diagnosis, CrCl <40 ml/min at diagnosis but improved to ⩾40 ml/min and CrCl <40 ml/min at diagnosis and remained <40 ml/min, were 112, 56 and 33 months, respectively (P<0.001). The complete renal response rate for patients with RI at diagnosis receiving novel agent induction therapy compared to the rest was 40 vs 16% (P<0.001). In conclusion, patients with reversal of RI have improved outcomes, but it remains inferior to patients with normal renal function at diagnosis. These results have implications for identifying early treatment strategies for patients at risk of developing renal insufficiency.

References

Aug 1, 1990·Archives of Internal Medicine·R AlexanianD Dixon
Jan 17, 2003·Mayo Clinic Proceedings·Robert A KylePhilip R Greipp
Jan 24, 2004·The Journal of Pharmacy and Pharmacology·T ErikssonG A Kaysen
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip R GreippJan Westin
Sep 9, 2008·The Journal of Pharmacology and Experimental Therapeutics·Rita SarköziHerbert Schramek
Mar 4, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Patrizia TosiMichele Cavo
May 26, 2010·Clinical Journal of the American Society of Nephrology : CJASN·John W Pickering, Zoltán H Endre
Jun 18, 2010·European Journal of Haematology. Supplementum·Jeffrey I Weitz
Sep 9, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz LudwigNiklas Zojer
Oct 20, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosJésus San Miguel
Aug 5, 2011·The New England Journal of Medicine·S Vincent RajkumarRobert A Kyle
Nov 3, 2011·Nature Reviews. Nephrology·Colin A HutchisonUNKNOWN International Kidney and Monoclonal Gammopathy Research Group
Sep 10, 2013·Blood Cancer Journal·A A Chanan-KhanM Q Lacy
Dec 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A DimopoulosE Kastritis
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Dec 3, 2014·The Lancet Oncology·S Vincent RajkumarJesus F San Miguel

❮ Previous
Next ❯

Citations

Nov 14, 2015·American Journal of Hematology·S Vincent Rajkumar
Jul 28, 2015·American Journal of Hematology·Wilson I GonsalvesLuciano J Costa
Jan 15, 2016·Mayo Clinic Proceedings·S Vincent Rajkumar, Shaji Kumar
Jul 19, 2016·Expert Review of Hematology·Despoina FotiouEfstathios Kastritis
Sep 13, 2016·Clinical Lymphoma, Myeloma & Leukemia·Caroline MoreauOlivier Decaux
Aug 12, 2016·Future Oncology·Wilson I GonsalvesFrancis K Buadi
Oct 21, 2016·Expert Opinion on Pharmacotherapy·Maria GavriatopoulouMeletios A Dimopoulos
Jul 30, 2016·British Journal of Haematology·Josephine M VosJorge J Castillo
Nov 3, 2016·Clinical Pharmacology and Therapeutics·J P LaubachD L Longo
Feb 13, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Yi QianXue Song
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosEvangelos Terpos
Apr 18, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Debajyoti BhowmikNianwen Shi
Mar 9, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christopher KimPaul C Cheng
Feb 12, 2019·Scientific Reports·Julia C WalkSarah A Holstein
Sep 1, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Krzysztof BatkoKatarzyna Krzanowska
Feb 23, 2020·American Journal of Hematology·Rajshekhar Chakraborty, Navneet S Majhail
Aug 11, 2020·American Journal of Hematology·Agoston Gyula SzaboAnnette Juul Vangsted
Sep 6, 2020·International Journal of Hematology·Ho Sup LeeUNKNOWN Korean Multiple Myeloma Working Party (KMMWP)
May 11, 2019·Bioscience Reports·Hirono IriuchishimaHiroshi Handa
Oct 20, 2018·Expert Review of Hematology·Dimitrios C ZiogasEfstathios Kastritis
May 3, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ben Sprangers
Sep 27, 2018·International Journal of Nephrology·Benjamin A DermanAgne Paner
Sep 2, 2018·Medicine·Ruili YuanXuan Guo
Jun 18, 2019·The Journal of Clinical Investigation·Wei-Zhong YingPaul W Sanders
Jan 19, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Tina Bech OlesenNiels Abildgaard
Jan 22, 2021·International Journal of Hematology·Seo-Yeon AhnJe-Jung Lee
Jan 28, 2021·Medical Sciences : Open Access Journal·Sandeep Anand PadalaGermame Hailegiorgis Ajebo
Jan 14, 2021·Kidney International·Frank BridouxUNKNOWN International Kidney and Monoclonal Gammopathy Research Group
Oct 30, 2019·Clinical Kidney Journal·Raphaël KormannJulie Peltier
Apr 1, 2021·Nature Reviews. Nephrology·Frank BridouxNelson Leung

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

JMP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.